Compounds > 2,6-dihydroxy-3-cyanopyridine
Page last updated: 2024-08-26

2,6-dihydroxy-3-cyanopyridine and Carcinoma, Epidermoid

2,6-dihydroxy-3-cyanopyridine has been researched along with Carcinoma, Epidermoid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyauchi, S; Okayasu, T; Sugiyama, K1

Other Studies

1 other study(ies) available for 2,6-dihydroxy-3-cyanopyridine and Carcinoma, Epidermoid

ArticleYear
Inhibition of catabolic pathway of 5-fluorouracil by 3-cyano-2,6-dihydroxypyridine in human lung cancer tissues.
    Japanese journal of cancer research : Gann, 1994, Volume: 85, Issue:1

    Topics: Adenocarcinoma; Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Phosphorylation; Pyridines

1994